Showing 321-330 of 9158 results for "".
Biologics Preferred after MACE in PsO, Plus More
https://practicaldermatology.com/series/dermwire-tv/biologics-preferred-after-mace-in-pso-plus-more/37882/In this edition of DermwireTV, new research shows biologic use use after MACE is persistent, signaling strong patient preference; a new study shows that early stress may raise lifelong psoriasis risk; and a new C-Suite Chat highlights a new antibody showing promise in treating atopic dermatitisAAD Leaders Discuss New Goals and Initiatives
https://practicaldermatology.com/series/dermwire-tv/aad-leaders-discuss-new-goals-and-initiatives/33154/In this week's DermwireTV, leaders of the American Academy of Dermatology (AAD) discuss the key issues facing the specialty; a new study examines nicotinamide exposure and the risk of major adverse cardiovascular events; and in our C-Suite Chats segment, we hear from an Executive Director at TakeLeading Dermatologists Summarize Maui Derm Presentations
https://practicaldermatology.com/series/dermwire-tv/leading-dermatologists-summarize-maui-derm-presentations/32839/In this week's DermwireTV, top thought leaders provide a summary of their presentations at Maui Derm; a new analysis examines a link between hidradenitis suppurativa genetics and coronary artery disease risk; and the president of Castle Biosciences joins us for this week's C-Suite Chats fNew Directions in Acne Care
https://practicaldermatology.com/topics/acne-rosacea/new-directions-in-acne-care/23515/Recent developments and therapeutic advancements continue to improve outcomes in the management of this common, inflammatory disease.Rosacea: A Closer Look at the Latest Treatment Options
https://practicaldermatology.com/programs/practical-dermatology/rosacea-a-closer-look-at-the-latest-treatment-options/23983/The latest treatments and expanded, responsible choices for treating patients with rosacea.Next Generation Environmental Protection: Antioxidants and Chelators
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/next-generation-environmental-protection-antioxidants-and-chelators/23802/As understanding of the pathogenesis of skin aging and carcinogenesis evolves, so do topical protective strategies.PA Perspectives - Building a Schedule
https://practicaldermatology.com/series/pa-perspectives/pa-perspectives-building-schedule/24488/In this video, Andrew Mastro, MS, PA-C, a board-certified physician assistant (PA) at the Illinois Dermatology Institute in Chicago, provides insights on what a PA should be providing to an MD and their office staff. He also discusses realistic expectations for a new PA regarding scheduling, and givWhat Should Dermatology PAs Know About Training and Onboarding
https://practicaldermatology.com/series/pa-perspectives/what-should-dermatology-pas-know-about-training-and-onboarding/24395/In this video, Andrew Mastro, MS, PA-C, a board-certified physician assistant (PA) at the Illinois Dermatology Institute in Chicago, discusses what realistic expectations PAs should have while training and onboarding in a new practice. Topics include what new PAs should expect at 30, 60, and 90 daysPASI-HD: New Method for Measuring Severity in Mild to Moderate Plaque Psoriasis
https://practicaldermatology.com/topics/psoriasis/pasi-hd-new-method-for-measuring-severity-in-mild-to-moderate-plaque-psoriasis/20185/Robert Higham, MPAS, PA-C, Executive Director of Clinical Development of Arcutis Biotherapeutics, discusses PASI-HD, a new measure designed to assess severity and therapeutic response in patients with mild and moderate psoriasis. PASI High Discrimination (PASI-HD) was developed to better understandUnderstanding the Role of Herbs in Cosmeceuticals
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/understanding-the-role-of-herbs-in-cosmeceuticals/20445/A unique herb blend in cosmeceuticals has shown clinical superiority over antioxidant and growth factor products.